title: [Personalized treatment in non-small cell lung cancer].
authors.affiliation: Laboratorio de Oncología Experimental, Instituto Nacional de Cancerología.
authors.forename: Alma Delia
authors.initials: AD
authors.lastname: Campos-Parra
authors.forename: Graciela
authors.initials: G
authors.lastname: Cruz-Rico
authors.forename: Oscar
authors.initials: O
authors.lastname: Arrieta
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics / Q000556:secondary; D000465:Algorithms; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy / Q000201:enzymology / Q000556:secondary; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics; D017322:Clinical Trials, Phase II as Topic / Q000706:statistics & numerical data; D000077547:Crizotinib; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000235:genetics; D000069347:Erlotinib Hydrochloride; D005260:Female; D011905:Genes, ras; D006801:Humans; D007889:Leiomyoma / Q000601:surgery; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics; D008875:Middle Aged; D058990:Molecular Targeted Therapy; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics; D016609:Neoplasms, Second Primary / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics; D015514:Oncogene Proteins, Fusion / Q000037:antagonists & inhibitors* / Q000235:genetics; D057285:Precision Medicine; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data; D014594:Uterine Neoplasms / Q000601:surgery
chemical_list: D000970:Antineoplastic Agents; C522504:EML4-ALK fusion protein, human; D009363:Neoplasm Proteins; D015514:Oncogene Proteins, Fusion; D047428:Protein Kinase Inhibitors; D011720:Pyrazoles; D011725:Pyridines; D011799:Quinazolines; D000077547:Crizotinib; D000069347:Erlotinib Hydrochloride; C512478:EGFR protein, human; D066246:ErbB Receptors